• Explore /
  • Poster
  • / Proof-of concept phase I study of everolimus, letrozole and trastuzumab in hormone receptor-positive, HER2-positive/amplified or mutant metastatic breast cancer or other solid tumors: Evaluating synergy and overcoming resistance.

Proof-of concept phase I study of everolimus, letrozole and trastuzumab in hormone receptor-positive, HER2-positive/amplified or mutant metastatic breast cancer or other solid tumors: Evaluating synergy and overcoming resistance.

Abstract Poster

Authors

null

Shubham Pant

Oklahoma University Health Sciences Center, Edmond, OK

Shubham Pant , Jennifer J. Wheler , Siqing Fu , David S. Hong , Daniel D. Karp , Vivek Subbiah , Apostolia Maria Tsimberidou , Veronica R. Holley , Abenaa M. Brewster , Kimberly Higginbotham Koenig , Nuhad K. Ibrahim , Rashmi Krishna Murthy , Funda Meric-Bernstam , Filip Janku

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2017 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Developmental Therapeutics—Clinical Pharmacology and Experimental Therapeutics

Track

Developmental Therapeutics and Translational Research

Sub Track

Small Molecules

Clinical Trial Registration Number

NCT02152943

Citation

J Clin Oncol 35, 2017 (suppl; abstr 2583)

DOI

10.1200/JCO.2017.35.15_suppl.2583

Abstract #

2583

Poster Bd #

75

Abstract Disclosures

Similar Posters

First Author: Jiayu Wang

First Author: Krystal Pauline Cascetta

First Author: Cristina Cruz Zambrano

First Author: Tejal Amar Patel